Stock ARDX ARDELYX, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases Ardelyx, Inc.

Equities

ARDX

US0396971071

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-31 pm EDT 		5-day change 1st Jan Change
6.855 USD +1.11% Intraday chart for Ardelyx, Inc. +1.56% +10.56%
May. 24 Ardelyx Shares Fall; Chief Commercial Officer Resigns MT
May. 23 Ardelyx, Inc. Announces Rodriguez Would Resign as Chief Commercial Officer CI

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Ardelyx, Inc. Reports Employment Inducement Grants
GL
Ardelyx to Participate at the 2024 Jefferies Global Healthcare Conference
GL
Ardelyx Presents Additional Data at the 2024 Digestive Disease Week Conference on IBSRELA® (tenapanor), a First-In-Class Treatment for IBS-C in Adults
GL
Ardelyx Presents Additional Data at the NKF 2024 Spring Clinical Meetings on XPHOZAH® (tenapanor)
GL
Ardelyx, Inc. Reports Employment Inducement Grants
GL
Ardelyx to Present Additional Data Supporting First-In-Class IBSRELA® (tenapanor) for Adults with Irritable Bowel Syndrome with Constipation at the 2024 Digestive Disease Week Conference
GL
Ardelyx: Q1 Earnings Snapshot
AQ
Ardelyx Reports First Quarter 2024 Financial Results and Provides Business Update
GL
Ardelyx to Present Additional Data Supporting First-In-Class XPHOZAH® (tenapanor) for Adults with Chronic Kidney Disease on Dialysis at the National Kidney Foundation 2024 Spring Clinical Meetings
GL
Ardelyx to Present Additional Data Supporting First-In-Class XPHOZAH® (tenapanor) for Adults with Chronic Kidney Disease on Dialysis at the National Kidney Foundation 2024 Spring Clinical Meetings
AQ
Ardelyx to Report First Quarter 2024 Financial Results on May 2, 2024
GL
Ardelyx, Inc. Reports Employment Inducement Grants
GL
Ardelyx Appoints Veteran BioPharma Executive, Mike Kelliher, as Executive Vice President, Corporate Development and Strategy
GL
Ardelyx Appoints Veteran BioPharma Executive, Mike Kelliher, as Executive Vice President, Corporate Development and Strategy
AQ
Ardelyx, Inc. Reports Employment Inducement Grants
GL
Ardelyx, Inc. Reports Employment Inducement Grants
AQ
Recent Market Movers: Healthcare Companies Making Headlines: DYAI, RIGL, ARDX, VERO, MEDS
AQ
Ardelyx to Participate at the Cowen 44th Annual Health Care Conference
GL
Ardelyx: Q4 Earnings Snapshot
AQ
Ardelyx Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
GL
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ARDX Stock
  4. News Ardelyx, Inc.
  5. Press Releases